Trial Profile

Proof of concept trial of PPP004

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 22 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PPP-004 (Primary)
Indications Epidermolysis bullosa
Focus Proof of concept; Therapeutic Use
Sponsors Tetra Bio Pharma

Most Recent Events

22 Apr 2020 New trial record
16 Apr 2020 According to tetra media release, the company will be assessing to launch a proof of concept trial in the coming months and will be requesting a Type B meeting with the US FDA to discuss the marketing requirements for this Orphan Drug indication.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com